These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Cigarette Smoking Status and Receipt of an Opioid Prescription Among Veterans of Recent Wars. Bastian LA; Driscoll MA; Heapy AA; Becker WC; Goulet JL; Kerns RD; DeRycke EC; Perez E; Lynch SM; Mattocks K; Kroll-Desrosiers AR; Brandt CA; Skanderson M; Bathulapalli H; Haskell SG Pain Med; 2017 Jun; 18(6):1089-1097. PubMed ID: 27659441 [TBL] [Abstract][Full Text] [Related]
43. Linkage of VA and State Prescription Drug Monitoring Program Data to Examine Concurrent Opioid and Sedative-Hypnotic Prescriptions among Veterans. Carlson KF; Gilbert TA; Morasco BJ; Wright D; Otterloo JV; Herrndorf A; Cook LJ Health Serv Res; 2018 Dec; 53 Suppl 3(Suppl Suppl 3):5285-5308. PubMed ID: 30088271 [TBL] [Abstract][Full Text] [Related]
44. Impact of Dual Use of Department of Veterans Affairs and Medicare Part D Drug Benefits on Potentially Unsafe Opioid Use. Gellad WF; Thorpe JM; Zhao X; Thorpe CT; Sileanu FE; Cashy JP; Hale JA; Mor MK; Radomski TR; Hausmann LRM; Donohue JM; Gordon AJ; Suda KJ; Stroupe KT; Hanlon JT; Cunningham FE; Good CB; Fine MJ Am J Public Health; 2018 Feb; 108(2):248-255. PubMed ID: 29267065 [TBL] [Abstract][Full Text] [Related]
45. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age. Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024 [TBL] [Abstract][Full Text] [Related]
46. Mental disorders and mental health treatment among U.S. Department of Veterans Affairs outpatients: the Veterans Health Study. Hankin CS; Spiro A; Miller DR; Kazis L Am J Psychiatry; 1999 Dec; 156(12):1924-30. PubMed ID: 10588406 [TBL] [Abstract][Full Text] [Related]
47. Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans. Lin LA; Bohnert ASB; Kerns RD; Clay MA; Ganoczy D; Ilgen MA Pain; 2017 May; 158(5):833-839. PubMed ID: 28240996 [TBL] [Abstract][Full Text] [Related]
48. Utilization of complementary and integrative health services and opioid therapy by patients receiving Veterans Health Administration pain care. Ashrafioun L; Allen KD; Pigeon WR Complement Ther Med; 2018 Aug; 39():8-13. PubMed ID: 30012396 [TBL] [Abstract][Full Text] [Related]
49. Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors. Oliva EM; Harris AH; Trafton JA; Gordon AJ Drug Alcohol Depend; 2012 May; 122(3):241-6. PubMed ID: 22115887 [TBL] [Abstract][Full Text] [Related]
50. Sedative Prescriptions Are Common at Opioid Initiation: An Observational Study in the Veterans Health Administration. Mosher HJ; Richardson KK; Lund BC Pain Med; 2018 Apr; 19(4):788-792. PubMed ID: 28340259 [TBL] [Abstract][Full Text] [Related]
51. The effect of medications for opioid use disorder (MOUD) on residential treatment completion and retention in the US. Stahler GJ; Mennis J Drug Alcohol Depend; 2020 Jul; 212():108067. PubMed ID: 32445926 [TBL] [Abstract][Full Text] [Related]
52. Families' perceptions of end-of-life care in Veterans Affairs versus non-Veterans Affairs facilities. Lu H; Trancik E; Bailey FA; Ritchie C; Rosenfeld K; Shreve S; Furman C; Smith D; Wolff C; Casarett D J Palliat Med; 2010 Aug; 13(8):991-6. PubMed ID: 20649437 [TBL] [Abstract][Full Text] [Related]
53. Menopausal Symptoms and Higher Risk Opioid Prescribing in a National Sample of Women Veterans with Chronic Pain. Gibson CJ; Li Y; Huang AJ; Rife T; Seal KH J Gen Intern Med; 2019 Oct; 34(10):2159-2166. PubMed ID: 31414358 [TBL] [Abstract][Full Text] [Related]
54. Predictors of Improvements in Pain Intensity in a National Cohort of Older Veterans With Chronic Pain. Dobscha SK; Lovejoy TI; Morasco BJ; Kovas AE; Peters DM; Hart K; Williams JL; McFarland BH J Pain; 2016 Jul; 17(7):824-35. PubMed ID: 27058162 [TBL] [Abstract][Full Text] [Related]
55. Treatment Of Opioid Use Disorder Among Commercially Insured US Adults, 2008-17. Shen K; Barrette E; Dafny LS Health Aff (Millwood); 2020 Jun; 39(6):993-1001. PubMed ID: 32479213 [TBL] [Abstract][Full Text] [Related]
56. Eight-hour medication-assisted treatment waiver training for opioid use disorder: integration into medical school curriculum. Lien IC; Seaton R; Szpytman A; Chou J; Webber V; Waineo E; Levine D Med Educ Online; 2021 Dec; 26(1):1847755. PubMed ID: 33222656 [No Abstract] [Full Text] [Related]
57. Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder. Chai D; Rosic T; Panesar B; Sanger N; van Reekum EA; Marsh DC; Worster A; Thabane L; Samaan Z JAMA Netw Open; 2021 Aug; 4(8):e2119600. PubMed ID: 34351402 [TBL] [Abstract][Full Text] [Related]
58. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder. Cole ES; DiDomenico E; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kim JY; Kmiec J; Kelley D; Donohue JM J Gen Intern Med; 2019 Jun; 34(6):936-943. PubMed ID: 30887440 [TBL] [Abstract][Full Text] [Related]
59. Beta-blocker Use is Associated with a Reduction in Opioid Use 30 Days After Total Knee Arthroplasty. Starr JB; Backonja M; Rozet I Pain Physician; 2019 Sep; 22(5):E395-E406. PubMed ID: 31561649 [TBL] [Abstract][Full Text] [Related]
60. The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use. Huhn AS; Tompkins DA; Dunn KE Drug Alcohol Depend; 2017 Nov; 180():279-285. PubMed ID: 28942031 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]